(株)中京医薬品の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4558/E03289 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2024/11/15 | 日証協 | 910,642株 | -10.76% | 69,400株 | -2.39% | 1,327,355株 | -5.74% | 42,700株 | +98.6% |
| 2024/11/08 | 日証協 | 1,020,442株 | -4.2% | 71,100株 | -65.83% | 1,408,155株 | -2.29% | 21,500株 | -41.26% |
| 2024/11/01 | 日証協 | 1,065,142株 | -7.21% | 208,100株 | -38.63% | 1,441,155株 | -1.7% | 36,600株 | -78.89% |
| 2024/10/25 | 日証協 | 1,147,942株 | +14.42% | 339,100株 | +23.85% | 1,466,055株 | +7.68% | 173,400株 | +328.13% |
| 2024/10/18 | 日証協 | 1,003,242株 | +5.88% | 273,800株 | +24.45% | 1,361,555株 | +2.64% | 40,502株 | -69.68% |
| 2024/10/11 | 日証協 | 947,542株 | +4.96% | 220,000株 | +42.95% | 1,326,553株 | +2.8% | 133,600株 | -6.8% |
| 2024/10/04 | 日証協 | 902,742株 | -12.49% | 153,900株 | -82.41% | 1,290,453株 | -3.08% | 143,353株 | -86.28% |
| 2024/09/27 | 日証協 | 1,031,610株 | +57.59% | 874,810株 | +923.17% | 1,331,429株 | +13.52% | 1,044,847株 | +327.34% |
| 2024/09/20 | 日証協 | 654,600株 | +9.23% | 85,500株 | +169.72% | 1,172,835株 | +19.26% | 244,500株 | +181.36% |
| 2024/09/13 | 日証協 | 599,300株 | -13.33% | 31,700株 | -58.67% | 983,435株 | -3.72% | 86,900株 | -16.05% |
| 2024/09/06 | 日証協 | 691,500株 | -15.05% | 76,700株 | -90.05% | 1,021,449株 | -5.87% | 103,517株 | -83.28% |
| 2024/08/30 | 日証協 | 814,000株 | +81.33% | 771,000株 | 0% | 1,085,148株 | +11.37% | 619,246株 | +2080.44% |
| 2024/08/23 | 日証協 | 448,900株 | -0.99% | 0株 | 0% | 974,365株 | -1.15% | 28,400株 | +263.64% |
| 2024/08/16 | 日証協 | 453,400株 | -0.83% | 0株 | 0% | 985,665株 | -1.74% | 7,810株 | -80.81% |
| 2024/08/09 | 日証協 | 457,200株 | 0% | 0株 | 0% | 1,003,155株 | -0.67% | 40,700株 | +825% |
| 2024/08/02 | 日証協 | 457,200株 | 0% | 0株 | 0% | 1,009,955株 | -0.6% | 4,400株 | -67.41% |
| 2024/07/26 | 日証協 | 457,200株 | 0% | 0株 | 0% | 1,016,055株 | -1.34% | 13,500株 | -12.97% |
| 2024/07/19 | 日証協 | 457,200株 | 0% | 0株 | 0% | 1,029,866株 | +0.35% | 15,512株 | +106.83% |
| 2024/07/12 | 日証協 | 457,200株 | 0% | 0株 | 0% | 1,026,254株 | 0% | 7,500株 | -24.24% |
※株式分割は考慮していませんのでご注意ください。
Page Top